Clinical trial
Multi-centre, Oral Single Dose Experimental and Modelling Study to Evaluate the Pharmacokinetics of Deferiprone in Patients Aged From 1 Month to Less Than 6 Years of Age Affected by Transfusion-dependent Haemoglobinopathies.
NCT01740713 is registered in ClinicalTrials.gov with Consorzio per Valutazioni Biologiche e Farmacologiche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-centre, Oral Single Dose Experimental and Modelling Study to Evaluate the Pharmacokinetics of Deferiprone in Patients Aged From 1 Month to Less Than 6 Years of Age Affected by Transfusion-dependent Haemoglobinopathies.
- Lead sponsor
- Consorzio per Valutazioni Biologiche e Farmacologiche
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- February 28, 2014
- Enrollment
- 23 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
chronic iron overload